white → yellow2 → brown2
dose.wiki is still in beta. Entries may contain inaccuracies and/or lack citations. See our docs for more info.
DET
N,N-diethyltryptamine
Diethyltryptamine, T-9
DET is a synthetic psychedelic of the tryptamine class, first synthesized by Stephen Szára in 1956.citation needed A close structural analog of DMT, it is distinguished by its oral activity, which results from increased resistance to monoamine oxidase metabolism. DET produces effects similar to DMT, including intense hallucinations and profound alterations in consciousness. It remains extremely uncommon with little history of human usage, and has no known natural sources.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Threshold~2 mg
Light2-15 mg
Moderate15-25 mg
Strong25-40 mg
Heavy40+ mg
Bioavailability
Low
2C-B exhibits a notably steep dose-response relationship, particularly within the 12–24 mg range, where differences of just 2 mg can substantially alter both the intensity and qualitative nature of the experience. Careful, incremental dosing is recommended when establishing individual sensitivity.
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
DET produces a psychedelic experience frequently compared to DMT in the character of its illusions and hallucinations, but one that is active orally and unfolds over a much longer, gentler arc, with effects often described as following a wave-like time course. Oral onset is slow, sometimes taking an hour or more to become undeniable, with peak intensity from roughly the first through third hour and full resolution by around five hours; smoked onset arrives within about five minutes and is notably gentle, euphoric, and empathogenic. The experience is strongly shaped by set and setting — favorable environments yield profound aesthetic, emotional, and philosophical states, while unfavorable ones or excessive doses can produce anxiety, paranoia, perplexity, and social withdrawal. A pleasant afterglow is commonly reported the following day, though higher doses can instead leave a hangover of lassitude and blunted, fuzzy thinking.
Physical
Body effects resemble the autonomic symptoms of DMT: sweating of the hands and feet, pupil dilation, pronounced tachycardia, and a hollowness in the chest, with dizziness, vertigo, paleness, shakiness, fine muscle tremor, athetoid movements, and occasional nausea or vomiting at stronger doses. Injected routes can produce a slight burning and numbness of the hands and feet during onset.
Autonomic
Stimulation
Mental and physical stimulation with restlessness is typical, and insomnia can follow.
Uncomfortable
Early physical symptoms tend to appear during onset and fade as the experience develops; DMT-like vegetative or autonomic symptoms are characteristic.
Cardiovascular
Cognitive
The headspace combines euphoria, empathy, and emotional insight with a sense of heightened meaning — objects can feel newly significant, and users describe perceiving the world anew like a small child, alongside cosmic, mystical, and philosophical currents of thought. This coexists with genuine impairment: drifting thoughts, difficulty concentrating, confusion, and an alcohol-like or stoned quality, and at anxious moments a peculiar double orientation in which the ordinary and the hallucinated world are held as real simultaneously.
Emotional
The emotional tone is typically euphoric, empathic, and open, but is highly dependent on set and setting; unfavorable conditions or excessive doses can invert it into anxiety and paranoia.
Enhancements
Suppressions
Transpersonal
Visual
Visual effects range from color intensification and closed-eye patterning at lighter doses to DMT-like illusions and hallucinations, with both closed- and open-eye visuals reported.
Hallucinatory States
Auditory
Music is enhanced and can contribute powerfully to the experience; auditory hallucinations have also been reported.
Tactile
Tactile sensation is enhanced, and physical touch can feel unusually rewarding and socially bonding.
Olfactory
Olfactory hallucinations have been reported.
Multisensory
See also: Psychedelic Intensity Scale, Effects of psychedelics (visual, cognitive, miscellaneous)
Pharmacology
Pharmacodynamics
DET acts as a non-selective serotonin receptor agonist, with activity at the 5-HT2A, 5-HT2B, and 5-HT2C receptors.citation needed At the 5-HT2A receptor, it activates Gq-mediated signaling with an Emax exceeding 70% and produces the head-twitch response in rodents, a behavioral proxy for psychedelic-like activity.3 The substance also exhibits very weak reversible monoamine oxidase inhibitory activity and may act as a serotonin reuptake inhibitor with low affinity but moderate potency,citation needed while showing no activity at the norepinephrine or dopamine transporters.
Pharmacokinetics
DET demonstrates significant resistance to monoamine oxidase metabolism, which may be attributable to the steric bulk of its N-ethyl substituents providing sufficient metabolic stability for oral activity.citation needed The substance is rapidly distributed through plasma, liver, and brain following administration, with most of the compound cleared from these tissues within 30 minutes, though it remains detectable in the brain at 60 minutes. DET is metabolized primarily through 6-hydroxylation of the indole ring and N-dealkylation, with approximately 20% of the administered dose excreted in urine as glucuronide conjugates. Repeated administration results in decreased excretion of unchanged drug and increased metabolite output.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Full Tolerance
Tolerance to the effects of DET develops almost immediately after ingestion.
Baseline Reset
7 days
Half Tolerance
Approximately 3 days
Cross Tolerance
Serotonergic psychedelics
Harm Potential
Addiction & Dependence
Psychological
Extremely LowDET is believed to be non-habit-forming, and the desire to use it may actually decrease with continued use, consistent with the typical profile of classic psychedelics.citation needed
Physical
Extremely LowNo physical dependence or withdrawal syndrome has been documented. Rapid tolerance development naturally limits frequent use patterns.citation needed
Psychosis Risk
Like other classic psychedelics, DET can produce acute psychotic-like symptoms including delusions, paranoia, and perceptual disturbances during intoxication. Early research explored DET as a psychotomimetic model, though this framework has since been largely dismissed by researchers. Risk may be elevated in predisposed individuals.citation needed
Seizure Risk
No direct seizure risk documented for DET alone. As with other psychedelics, it may act as a seizure trigger in predisposed individuals, particularly when combined with substances that lower seizure threshold.
History & Culture
DET was first synthesized in 1956 by Hungarian chemist Stephen Szára, with his findings published the following year.citation needed More systematic studies were subsequently conducted by Szára and colleagues, as well as independently by Böszörményi and…
Legality
International
DET (N,N-diethyltryptamine) is listed in Schedule I of the 1971 Convention on Psychotropic Substances. It is not listed in the schedules to the 1961 Single Convention on Narcotic Drugs or in Tables I and II of the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
By Country
Illegal24
United StatesIllegalControlled under the Controlled Substances Act as a Schedule I hallucinogen, indicating high abuse potential and no accepted medical use.39 Manufacturing, buying, possessing, or distributing without a DEA license is a federal offense.
By state
Across the 50 states, D.C., and the permanent territories, most jurisdictions treat DET consistently with federal control; listed entries record independently verified differences in state classification or coverage.
MaineIllegalMe. Rev. Stat. tit. 17-A, § 1102(2)(H)(5)44
Maine classifies diethyltryptamine (DET) as a Schedule X hallucinogenic drug. DET is prohibited under Maine's drug-crime schedules, rather than being placed in the federal Schedule I designation.
MassachusettsIllegalMass. Gen. Laws ch. 94C, § 31, Class C(e)(5)45
Massachusetts lists diethyltryptamine as a Class C controlled substance. This state classification prohibits DET while assigning it to Class C rather than the federal Schedule I designation.
AustraliaIllegalControlled under the Poisons Standard.24 Classified as a substance subject to abuse or misuse; manufacture, possession, sale, or use is prohibited except for approved medical or scientific research, analytical, teaching, or training purposes with Commonwealth and/or State or Territory Health Authority approval.
AustriaIllegalSuchtgiftverordnung15
DET is listed in Anhang V of the Suchtgiftverordnung among the substances in Schedule I of the 1971 Convention. It is therefore a Suchtgift under the Suchtmittelgesetz and subject to the Act’s controls.
BrazilIllegalPortaria SVS/MS nº 344, de 12 de maio de 19989
DET is listed in Lista F2 of the Brazilian controlled-substances lists attached to Portaria SVS/MS No. 344. Substances in that list are subject to the national special-control regime.
ColombiaIllegalDecree No. 120 of 199221
DET is included in Lista I of the 1971 Convention text promulgated by Decree No. 120 of 1992. For Lista I substances, Article 7 requires parties to prohibit use except authorised scientific use and very limited medical use under strict supervision.
Czech RepublicIllegalGovernment Regulation No. 463/2013 Coll. on lists of addictive substances40
N,N-Diethyltryptamine (DET) is listed in the Schedule 4 psychotropic-substances list in Government Regulation No. 463/2013 Coll. The regulation places the substance in the Czech controlled-substances system.
DenmarkIllegalBekendtgørelse om euforiserende stoffer16
DET is listed individually in Liste B of the Executive Order on Euphoriant Substances. Listed substances and preparations containing them are subject to Denmark’s narcotics controls.
FinlandIllegalValtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista (543/2008)17
DET is listed in Lista I of the Government Decree on substances, preparations, and plants regarded as narcotics. The list implements the Schedule I controls of the 1971 Convention in Finnish law.
IndiaIllegalNarcotic Drugs and Psychotropic Substances Act, 19854
N,N-Diethyltryptamine is listed in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 as a psychotropic substance. Section 8 prohibits production, manufacture, possession, sale, purchase, transport, use, consumption, import, and export except as authorised for medical or scientific purposes.
MexicoIllegalLey General de Salud12
DET is included in Group I of Article 245 of the Ley General de Salud. Article 248 prohibits the acts described in Article 247 in relation to Group I substances, while Article 249 permits acquisition only when authorised for scientific research.
NetherlandsIllegalOpiumwet25
N,N-Diethyltryptamine (DET) is listed in Lijst I of the Opiumwet. The Act prohibits the manufacture, sale, supply, transport, import, export, and possession of List I substances except as authorised.
NorwayIllegalForskrift om narkotika (narkotikaforskriften)13
DET is entered in Norway’s narcotics list as N,N-dietyltryptamin. The narcotics regulation controls possession, manufacture, import, export, and other handling of listed substances unless authorised.
PhilippinesIllegalRepublic Act No. 9165, Comprehensive Dangerous Drugs Act of 200228
DET is included in Schedule I of the Comprehensive Dangerous Drugs Act of 2002. The Act prohibits unauthorised importation, sale, administration, delivery, distribution, transportation, manufacture, possession, and use of dangerous drugs.
PolandIllegalRozporządzenie Ministra Zdrowia w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych14
DET is classified as a psychotropic substance in group I-P under the Minister of Health regulation implementing the Act on Counteracting Drug Addiction. Unauthorised possession, manufacture, and trade in substances in that controlled category are prohibited.
South AfricaIllegalDrugs and Drug Trafficking Act 140 of 1992, as amended by Drugs and Drug Trafficking Amendment Act 14 of 202233343536
Diethyltryptamine is listed in Part III of Schedule 2 to the Drugs and Drug Trafficking Act 140 of 1992 as an undesirable dependence-producing substance. Sections 4 and 5 prohibit its use, possession, and dealing except in the limited lawful circumstances specified by the Act and the Medicines and Related Substances Act framework. The 2022 amendment substituted the current Schedules 1 and 2 and retained diethyltryptamine in Part III.
South KoreaIllegalEnforcement Decree of the Narcotics Control Act29
DET is listed in Schedule 3 of the Enforcement Decree of the Narcotics Control Act as a psychotropic drug. Its manufacture, handling, possession, import, and export are subject to the Act’s narcotics controls.
SpainIllegalReal Decreto 2829/1977, de 6 de octubre8
DET is listed as dietiltriptamina in Lista I of the psychotropic-substances schedules annexed to Real Decreto 2829/1977. The decree subjects listed psychotropic substances to controls on manufacture, distribution, prescription, and dispensing.
UkraineIllegalResolution of the Cabinet of Ministers No. 770 of 6 May 200020
DET is listed in List No. 2 of Table I of Ukraine’s List of Narcotic Drugs, Psychotropic Substances and Precursors. This table designates especially dangerous psychotropic substances whose circulation is prohibited.
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- LStep 2 · First-pass review
A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the DET article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.
